- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02790892
Creative Arts Diabetes Initiative for Youth/Young Adults Transitioning to Adult Care (CADI)
Creative Arts Diabetes Initiative: Group Art Therapy and Peer Support for Youth and Young Adults Transitioning From Pediatric to Adult Diabetes Care
Study Overview
Status
Intervention / Treatment
Detailed Description
The Creative Arts Diabetes Initiative will offer facilitated art therapy with a group/peer-support environment to two groups of youth/young adults, one with type 1 diabetes, and one with type 2 diabetes. This environment intends to "meet youth where they are", promote universality, hope and self-understanding, has the potential to be therapeutic and allows youth to express and learn about themselves and each other while developing healthy coping skills and address their fears and concerns.
As much of diabetes management is about meeting physical health goals - it is the vision of this study that offering additional support in the form of art therapy will have positive effects for bringing awareness and avenues for self-care to the other often neglected dimensions of patients' mental, emotional and spiritual health as part of a more holistic health process.
Engaging in art therapy has the potential to decrease diabetes related distress by giving youth a means and opportunity to identify, understand and express their feelings about having diabetes. Improved self-awareness and self-reflectiveness can help youth integrate their feelings and learn how this can motivate, influence and impact their behaviors and life choices.
Youth will have the opportunity for engaging in peer support, and to build relationships that are meaningful, thus increasing their sense of belonging and positively affect their level of self-confidence, purpose and wellbeing.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P4
- University of Manitoba
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosed with either type 1 or type 2 diabetes, live within weekly travel distance to Winnipeg, Manitoba, receive their pediatric care at the Diabetes Education Resource for Children and Adolescents, or who are members of the Maestro Project
Exclusion Criteria:
- those who cannot give informed consent or who are not able to attend regular sessions due to travel distance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Art therapy - pre and post test measures
20 young adults aged 15-24 years with diabetes (10 with type 1 diabetes and 10 with type 2 diabetes) receiving 12 weeks of group art therapy.
Participants serve as their own controls.
|
12 weeks of 90 minutes of art therapy with pre and post test measures to determine changes in social support and levels of diabetes distress
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decrease diabetes related distress
Time Frame: 12 weeks
|
Decrease diabetes related distress as measured by the Diabetes Attitudes Wishes and Needs Study (DAWN) Problem Areas in Diabetes Questionnaire (PAID).
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Increase social support
Time Frame: 12 weeks
|
Increase emotional and social support for youth as measured by Measures of Support (MOS) Social Support Survey.
|
12 weeks
|
Increase emotional
Time Frame: 12 weeks
|
Increase emotional and social support for youth as measured by Mental Health Continuum Short Form (MHC-SF)
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Seth D Marks, MD,MSc,FRCPC, University of Manitoba, Pediatric Endocrinology
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS19577 (H2016:119)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
DiabeloopUniversity Hospital, Grenoble; AGIR à Dom; Icadom; Centre Hospitalier Annecy Genevois and other collaboratorsCompletedDiabetes Mellitus Type 2 - Insulin-TreatedFrance
Clinical Trials on Art therapy - pre and post test measures
-
University of RochesterCompleted
-
Cairo UniversityActive, not recruitingStress Urinary IncontinenceEgypt
-
National Institute of Allergy and Infectious Diseases...Completed
-
Necmettin Erbakan UniversityNot yet recruitingNurse-Patient Relations
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Methodist Health SystemCompletedCardiovascularUnited States
-
Kafkas UniversityNot yet recruiting
-
Centre hospitalier de l'Université de Montréal...Université de MontréalCompletedMedical EducationCanada
-
Universidad IberoamericanaClemson UniversityCompletedDiabetes Mellitus, Type 1Dominican Republic
-
Suleyman Demirel UniversityCompletedNursing StudentsTurkey